Personalis, Inc. (PSNL): Price and Financial Metrics


Personalis, Inc. (PSNL)

Today's Latest Price: $14.99 USD

0.15 (-0.99%)

Updated Jul 10 4:00pm

Add PSNL to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 338 in Biotech

See all "A" rated Strong Buy stocks

PSNL Stock Summary

  • PSNL's went public 1.06 years ago, making it older than only 0.52% of listed US stocks we're tracking.
  • The ratio of debt to operating expenses for Personalis Inc is higher than it is for about just 0.34% of US stocks.
  • With a year-over-year growth in debt of -100%, Personalis Inc's debt growth rate surpasses merely 0% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Personalis Inc are CERS, KIN, JG, MRAM, and CTIC.
  • PSNL's SEC filings can be seen here. And to visit Personalis Inc's official web site, go to www.personalis.com.
PSNL Daily Price Range
PSNL 52-Week Price Range

PSNL Stock Price Chart Technical Analysis Charts


PSNL Price/Volume Stats

Current price $14.99 52-week high $25.64
Prev. close $15.14 52-week low $4.27
Day low $14.73 Volume 247,438
Day high $15.49 Avg. volume 368,148
50-day MA $12.45 Dividend yield N/A
200-day MA $10.52 Market Cap 475.33M

Personalis, Inc. (PSNL) Company Bio


Personalis, Inc. provides genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.


PSNL Latest News Stream


Event/TimeNews Detail
Loading, please wait...

PSNL Latest Social Stream


Loading social stream, please wait...

View Full PSNL Social Stream

Latest PSNL News From Around the Web

Below are the latest news stories about Personalis Inc that investors may wish to consider to help them evaluate PSNL as an investment opportunity.

Personalis, Inc. (PSNL) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Personalis, Inc. (PSNL).

Yahoo | July 10, 2020

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Personalis, Inc. - PSNL

NEW YORK, July 03, 2020 -- Pomerantz LLP is investigating claims on behalf of investors of Personalis, Inc.  (“Personalis” or the “Company”) (NASDAQ: PSNL).   Such investors.

Yahoo | July 3, 2020

Personalis Completes Sequencing 75,000th Whole Human Genome for VA MVP

MENLO PARK, Calif.--(BUSINESS WIRE)-- #PrecisionOncology--Personalis Completes Sequencing 75,000th Whole Human Genome for VA MVP

Business Wire | June 24, 2020

Personalis Announces New Data to be Presented at AACR Virtual Scientific Meeting

MENLO PARK, Calif.--(BUSINESS WIRE)-- #AACR20--Personalis Announces New Data to be Presented at AACR Virtual Scientific Meeting

Business Wire | June 22, 2020

Personalis to Participate in European Association for Cancer Research (EACR) 2020 Virtual Congress

Personalis to Participate in European Association for Cancer Research (EACR) 2020 Virtual Congress

Yahoo | June 18, 2020

Read More 'PSNL' Stories Here

PSNL Price Returns

1-mo 28.23%
3-mo 79.74%
6-mo 37.27%
1-year -40.84%
3-year N/A
5-year N/A
YTD 37.52%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7863 seconds.